Clinical Trial Update: Antiemetic Therapy With or Without Olanzapine in Preventing Chemotherapy-Induced Nausea and Vomiting in Patients With Cancer Receiving Highly Emetogenic Chemotherapy [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating whether adding olanzapine to standard antiemetic therapy improves prevention of chemotherapy-induced nausea and vomiting in cancer pati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Cancer
• Solid Tumors

Drugs mentioned

• olanzapine (olanzapine)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Hematopoietic/Lymphoid Cancer, Nausea and Vomiting | Phase 3 | Status: COMPLETED | Results posted: 2017-04-10